Thiyagaraja Ravindran
Directeur/Membre du Conseil chez UCB Fipar SA
Profil
Thiyagaraja Ravindran is currently a Director at UCB Fipar SA since 2018.
Prior to this, he worked as a Director at Zogenix, Inc.
Postes actifs de Thiyagaraja Ravindran
| Sociétés | Poste | Début |
|---|---|---|
UCB Fipar SA
 UCB Fipar SA Financial ConglomeratesFinance Part of UCB SA, UCB Fipar SA is an investment holding Belgian company. The private company is based in Anderlecht, Belgium. UCB Fipar was founded in 1947. | Directeur/Membre du Conseil | 09/02/2018 |
Anciens postes connus de Thiyagaraja Ravindran
| Sociétés | Poste | Fin |
|---|---|---|
| ZOGENIX, INC. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
UCB Fipar SA
UCB Fipar SA Financial ConglomeratesFinance Part of UCB SA, UCB Fipar SA is an investment holding Belgian company. The private company is based in Anderlecht, Belgium. UCB Fipar was founded in 1947. | Finance |
Zogenix, Inc.
 Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. | Health Technology |
